Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

AETHLON MEDICAL INC

AEMD · Nasdaq · CIK 0000882291 · Healthcare · Medical Devices

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

8 Form 4 transaction lines observed in the same window
0 sales · 8 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Shah ChetanDirector
○○
Gikakis NicolasDirector
○○
BROENNIMAN EDWARD GDirector
○○
FRAKES JAMES BCFO/CEO
○
LAROSA STEVEN PChief Medical Officer
○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
0Sales
15Other Form 4 lines
15SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER8 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+238.1%
3M
+78.8%
6M
-38.7%
12M
-83.7%

Volatility & liquidity

Volatility
304.4%
Beta
1.21
Avg daily value
USD 16.7M

Valuation

Market cap
USD 10.5M
P/E
—

Fundamentals

Profit margin
0.0%
ROE
-146.3%
Industry
Medical Devices

Market data

Price data up to: 2026-10-05 · Price source: OpenBB/yfinance · From SEC filings: ROE · Fiscal year ended: 2026-03-31 · From Yahoo Finance: Market cap, Profit margin · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
75,446
Previous report
74,846
Avg daily volume
8,417,425
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

15 transaction lines in the latest 365-day window; 118 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-08LAROSA STEVEN PAward / grant (A)Common Stock42,000USD 0.00USD 0SEC filing ↗
2026-10-08FRAKES JAMES BAward / grant (A)Common Stock42,000USD 0.00USD 0SEC filing ↗
2026-09-30Shah ChetanTax withholding (F)Common Stock436USD 6.52USD 2,843SEC filing ↗
Show recent Form 4 evidence (15 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-08LAROSA STEVEN PAward / grant (A)Common Stock42,000USD 0.00USD 0SEC filing ↗
2026-10-08FRAKES JAMES BAward / grant (A)Common Stock42,000USD 0.00USD 0SEC filing ↗
2026-09-30Shah ChetanTax withholding (F)Common Stock436USD 6.52USD 2,843SEC filing ↗
2026-09-30Gikakis NicolasTax withholding (F)Common Stock436USD 6.52USD 2,843SEC filing ↗
2026-09-30BROENNIMAN EDWARD GTax withholding (F)Common Stock218USD 6.52USD 1,421SEC filing ↗
2026-06-30Shah ChetanTax withholding (F)Common Stock2,182USD 0.82USD 1,789SEC filing ↗
2026-06-30Gikakis NicolasTax withholding (F)Common Stock2,182USD 0.82USD 1,789SEC filing ↗
2026-06-30BROENNIMAN EDWARD GTax withholding (F)Common Stock1,091USD 0.82USD 895SEC filing ↗
2026-04-17Shah ChetanAward / grant (A)Common Stock21,815USD 2.29USD 49,956SEC filing ↗
2026-04-17Rossetti AngelaAward / grant (A)Common Stock21,815USD 2.29USD 49,956SEC filing ↗
2026-04-17Gikakis NicolasAward / grant (A)Common Stock21,815USD 2.29USD 49,956SEC filing ↗
2026-04-17BROENNIMAN EDWARD GAward / grant (A)Common Stock21,815USD 2.29USD 49,956SEC filing ↗
2025-12-31Shah ChetanTax withholding (F)Common Stock179USD 2.77USD 496SEC filing ↗
2025-12-31Gikakis NicolasTax withholding (F)Common Stock179USD 2.77USD 496SEC filing ↗
2025-12-31BROENNIMAN EDWARD GTax withholding (F)Common Stock89USD 2.77USD 247SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerAEMD
CIK0000882291
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeNasdaq

Data coverage

Local Form 4 history118 transaction lines from 2020-01-31 to 2026-10-08
0 P purchase lines · 3 S sale lines · 115 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.